These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25081058)

  • 41. Fas-associated factor 1 is a scaffold protein that promotes β-transducin repeat-containing protein (β-TrCP)-mediated β-catenin ubiquitination and degradation.
    Zhang L; Zhou F; Li Y; Drabsch Y; Zhang J; van Dam H; ten Dijke P
    J Biol Chem; 2012 Aug; 287(36):30701-10. PubMed ID: 22730322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors.
    Huang WK; Akçakaya P; Gangaev A; Lee L; Zeljic K; Hajeri P; Berglund E; Ghaderi M; Åhlén J; Bränström R; Larsson C; Lui WO
    Exp Cell Res; 2018 Oct; 371(1):287-296. PubMed ID: 30149002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SCF β-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration.
    Zhong J; Shaik S; Wan L; Tron AE; Wang Z; Sun L; Inuzuka H; Wei W
    Oncotarget; 2013 Dec; 4(12):2339-53. PubMed ID: 24318128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells.
    Yuan T; Wang Y; Zhao ZJ; Gu H
    J Biol Chem; 2010 May; 285(20):14861-14870. PubMed ID: 20335174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HECT E3 ubiquitin ligase Nedd4-1 ubiquitinates ACK and regulates epidermal growth factor (EGF)-induced degradation of EGF receptor and ACK.
    Lin Q; Wang J; Childress C; Sudol M; Carey DJ; Yang W
    Mol Cell Biol; 2010 Mar; 30(6):1541-54. PubMed ID: 20086093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PEST motif sequence regulating human NANOG for proteasomal degradation.
    Ramakrishna S; Suresh B; Lim KH; Cha BH; Lee SH; Kim KS; Baek KH
    Stem Cells Dev; 2011 Sep; 20(9):1511-9. PubMed ID: 21299413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PTPN18 Serves as a Potential Oncogene for Glioblastoma by Enhancing Immune Suppression.
    Wang T; Yu Y; Ba X; Zhang X; Zhang N; Wang G; Bai B; Li T; Zhao J; Zhao Y; Wang B
    Oxid Med Cell Longev; 2023; 2023():2994316. PubMed ID: 36846716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trastuzumab and lapatinib modulation of HER2 tyrosine/threonine phosphorylation and cell signaling.
    Kostyal D; Welt RS; Danko J; Shay T; Lanning C; Horton K; Welt S
    Med Oncol; 2012 Sep; 29(3):1486-94. PubMed ID: 21769502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis.
    Kumar KG; Barriere H; Carbone CJ; Liu J; Swaminathan G; Xu P; Li Y; Baker DP; Peng J; Lukacs GL; Fuchs SY
    J Cell Biol; 2007 Dec; 179(5):935-50. PubMed ID: 18056411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PTPN12/PTP-PEST Regulates Phosphorylation-Dependent Ubiquitination and Stability of Focal Adhesion Substrates in Invasive Glioblastoma Cells.
    Chen Z; Morales JE; Guerrero PA; Sun H; McCarty JH
    Cancer Res; 2018 Jul; 78(14):3809-3822. PubMed ID: 29743287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ubiquitination of neuronal nitric-oxide synthase in the calmodulin-binding site triggers proteasomal degradation of the protein.
    Clapp KM; Peng HM; Jenkins GJ; Ford MJ; Morishima Y; Lau M; Osawa Y
    J Biol Chem; 2012 Dec; 287(51):42601-10. PubMed ID: 23109339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tyrosine phosphatases in the HER2-directed motility of ovarian cancer cells: Involvement of PTPN12, ERK5 and FAK.
    Villa-Moruzzi E
    Anal Cell Pathol (Amst); 2011; 34(3):101-12. PubMed ID: 21483099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction.
    Wang Z; Inuzuka H; Zhong J; Fukushima H; Wan L; Liu P; Wei W
    Oncotarget; 2012 Sep; 3(9):1026-35. PubMed ID: 22976441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Way TD; Kao MC; Lin JK
    J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.
    Brennan K; McSherry EA; Hudson L; Kay EW; Hill AD; Young LS; Hopkins AM
    Oncogene; 2013 May; 32(22):2799-804. PubMed ID: 22751120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidermal Growth Factor Receptor activation promotes ADA3 acetylation through the AKT-p300 pathway.
    Srivastava S; Mohibi S; Mirza S; Band H; Band V
    Cell Cycle; 2017 Aug; 16(16):1515-1525. PubMed ID: 28759294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO).
    Menendez JA; Vazquez-Martin A; Garcia-Villalba R; Carrasco-Pancorbo A; Oliveras-Ferraros C; Fernandez-Gutierrez A; Segura-Carretero A
    BMC Cancer; 2008 Dec; 8():377. PubMed ID: 19094209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation.
    Vogel W; Lammers R; Huang J; Ullrich A
    Science; 1993 Mar; 259(5101):1611-4. PubMed ID: 7681217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.
    Szalmás A; Tomaić V; Basukala O; Massimi P; Mittal S; Kónya J; Banks L
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
    Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.